Our Company
AboutReact4Life
We think as biologists, feel as researchers and act like engineers.
The peculiarity of React4Life is the coexistence of strategic vision along with technical and scientific skills in the team that help to seize the needs of the life science world and provide them with effective technological solutions.
By working with the world’s leading scientists in the field of tissue engineering, 3D tissue models and cellular biology, we aim to advance disease knowledge and drug testing by MIVO® technology, the next generation of effective in vitro 3D fluid-dynamic assays.
Our History
React4life was launched in 2016 as an innovative company by a team of scientists and promoters of breakthrough technologies.
In 2010 Maurizio Aiello, a physicist with several interests in science, technology, emerging trends and economics, met Silvia Scaglione, a bioengineer researcher with significant international scientific experience in tissue engineering, biomaterials and bioreactors.
In 2016 React4life was founded and a team of scientists and promoters of breakthrough technologies started to join them both in the headquarter and lab in Genoa.
Scientific validations and happy clients among high-level institutions, research centres and pharma companies consider MIVO® – Multi In Vitro Organ as the most innovative organ-on-chip technology; it can emulate the human biology in vitro towards more predictive and reliable models.
Our Vision
We have the ambition to turn the promise of biomedical research into concrete benefits for society.
Our Mission
We aim to spread our cutting-edge MIVO® technology and increase the number of its applications, making it a standard in vitro tool for everyday testing. Our goal is to accelerate drug development and boost personalized oncological medicine.
Our Values
We believe in high-quality standards and sound scientific results to lead our products to excellence.
Honesty, efficiency, reliability and respect are principles behind our relationships with customers, suppliers and partners.
Our Awards
Our Team
Founders

Dr. Maurizio Aiello
CEO
Physicist & Founder and CEO in 3 startups
Italian delegate to European Commission
(H2020 program)
President of SOSIA Technological pole
Author of more than 60 scientific papers
Past President Technological District SIIT

Eng. Silvia Scaglione
CSO
PhD in Biomedical Engineering
Author of more than 100 scientific papers
Inventor of 7 patents
ITWIIN best inventor 2019 award
FET Open Horizon 2020 Project coordinator
European Innovation Council Ambassador
Advisors
NEWS & EVENTS
Our updates
Stay Up-to-Date with Our Latest News and Events.
We are always on the move and want to keep you in the loop!
Check out our the latest news and events, including important announcements, exciting milestones, and events where you can come and meet us in person!
React4life and Prodeco Pharma Announce Exciting Partnership in Evidence-Based Botanical Research
React4life partners with Prodeco Pharma, combining the patented MIVO® organ‑on‑chip platform with phytotherapy…
Breaking barriers in biotech – the EIC Women Leadership Programme and React4Life’s co‑founder Silvia Scaglione
Silvia Scaglione’s interview on the European Innovation Council Women Leadership Programme is now live. Read the full…
Mac4Me project kicks off with a meeting in Rotterdam and the first doctoral training session
The Mac4Me project officially took off in Rotterdam, where Erasmus University Medical Center hosted its kick-off…
FDA Phases Out Animal Testing: React4life at the Forefront of Drug Innovation
The FDA’s move to phase out animal testing in monoclonal antibody development marks a major shift in regulatory…
React4life awarded the “Premio America Innovazione” at the Italian Parliament
React4life is proud to be honored with the America Innovation Award by the Italy–USA Foundation. This recognition…
Mac4Me Project: Macrophage Targets for Metastatic Treatment
Mac4Me, an innovative Horizon Europe Marie Skłodowska-Curie Actions Doctoral Network, brings together 14 international…
SLAS INTERNATIONAL 2025
React4life attended the 2025 SLAS conference in San Diego. The event connects scientists with the latest laboratory…



































